17-alpha-hydroxyprogesterone and Fetal Membranes, Premature Rupture

17-alpha-hydroxyprogesterone has been researched along with Fetal Membranes, Premature Rupture in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Biron-Shental, T; Cohen, G; Miller, N; Moran, R; Ovadia, M; Schreiber, H; Shavit, M; Shechter-Maor, G; Weitzner, O; Yagur, Y	1
Kumar, D; Lockwood, CJ; Mansour, JM; Mercer, BM; Mesiano, S; Moore, JJ; Moore, RM; Philipson, E; Schatz, F; Springel, E	1
Briery, CM; Chauhan, SP; Klauser, CK; Magann, EF; Martin, RW; Morrison, JC; Veillon, EW	1

Trials

1 trial(s) available for 17-alpha-hydroxyprogesterone and Fetal Membranes, Premature Rupture

Article	Year
Women with preterm premature rupture of the membranes do not benefit from weekly progesterone. American journal of obstetrics and gynecology, 2011, Volume: 204, Issue:1 Topics: 17-alpha-Hydroxyprogesterone; Adult; Algorithms; Drug Administration Schedule; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Gestational Age; Humans; Labor Stage, First; Mississippi; Pregnancy; Premature Birth; Statistics, Nonparametric; Young Adult	2011

Article

Year

Women with preterm premature rupture of the membranes do not benefit from weekly progesterone.

American journal of obstetrics and gynecology, 2011, Volume: 204, Issue:1

Topics: 17-alpha-Hydroxyprogesterone; Adult; Algorithms; Drug Administration Schedule; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Gestational Age; Humans; Labor Stage, First; Mississippi; Pregnancy; Premature Birth; Statistics, Nonparametric; Young Adult

2011

Other Studies

2 other study(ies) available for 17-alpha-hydroxyprogesterone and Fetal Membranes, Premature Rupture

Article	Year
Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM? PloS one, 2022, Volume: 17, Issue:5 Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Premature Birth; Retrospective Studies	2022
Progesterone inhibits in vitro fetal membrane weakening. American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:4 Topics: 17-alpha-Hydroxyprogesterone; Chorion; Decidua; Extraembryonic Membranes; Female; Fetal Membranes, Premature Rupture; Granulocyte-Macrophage Colony-Stimulating Factor; Hemostatics; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Pregnancy; Progesterone; Progestins; Thrombin; Tumor Necrosis Factor-alpha	2015

Article

Year

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?

PloS one, 2022, Volume: 17, Issue:5

Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Premature Birth; Retrospective Studies

2022

Progesterone inhibits in vitro fetal membrane weakening.

American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:4

Topics: 17-alpha-Hydroxyprogesterone; Chorion; Decidua; Extraembryonic Membranes; Female; Fetal Membranes, Premature Rupture; Granulocyte-Macrophage Colony-Stimulating Factor; Hemostatics; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Pregnancy; Progesterone; Progestins; Thrombin; Tumor Necrosis Factor-alpha

2015